Published on May 12, 2021
Update on Multiple Myeloma Clinical Trials and Treatments
Follow along as Patient Power co-founders Andrew Schorr and Esther Schorr discuss the latest updates in clinical trials and treatments for multiple myeloma with two renowned experts. Dr. Rafael Fonseca, MD, FACP, Interim Director of the Mayo Clinic Cancer Center, and Dr. Krina Patel, MD, MSc, Assistant Professor in the Department of Lymphoma/Myeloma at the University of Texas MD Anderson Cancer Center, will also share information on the recent approval of CAR T-cell therapy for multiple myeloma.
Support for this series has been provided by Sanofi Genzyme. Patient Power maintains complete editorial control and is solely responsible for program content.